BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 55 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q1 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $40,000 | -16.7% | 12,000 | 0.0% | 0.01% | -20.0% |
| Q4 2021 | $48,000 | +20.0% | 12,000 | 0.0% | 0.01% | +11.1% |
| Q3 2021 | $40,000 | -13.0% | 12,000 | -0.0% | 0.01% | -18.2% |
| Q2 2021 | $46,000 | 0.0% | 12,003 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $46,000 | -14.8% | 12,003 | 0.0% | 0.01% | -26.7% |
| Q4 2020 | $54,000 | -73.4% | 12,003 | 0.0% | 0.02% | -78.3% |
| Q3 2020 | $203,000 | +50.4% | 12,003 | 0.0% | 0.07% | +32.7% |
| Q2 2020 | $135,000 | +141.1% | 12,003 | +0.0% | 0.05% | +73.3% |
| Q1 2020 | $56,000 | +9.8% | 12,000 | 0.0% | 0.03% | +36.4% |
| Q4 2019 | $51,000 | – | 12,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 189,935 | $311,494 | 0.08% |
| ABNER HERRMAN & BROCK LLC | 280,000 | $459 | 0.07% |
| Weaver Consulting Group | 65,947 | $108,153 | 0.06% |
| S.C. Financial Services, Inc. | 25,372 | $41,610 | 0.03% |
| JMAC ENTERPRISES LLC | 40,430 | $66,305 | 0.02% |
| Weaver Consulting Group | 53,500 | $10,047 | 0.01% |
| IFP Advisors, Inc | 26,650 | $139 | 0.00% |
| Bangor Savings Bank | 4,000 | $7 | 0.00% |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 3,000 | $4,920 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 19,098 | $31,321 | 0.00% |